Clinical Trial Update: Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity [Phase 2]

View source ↗

Summary

Phase II study assessing safety, pharmacokinetics, and efficacy of SL-1002 for limb spasticity is in progress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• SL-1002

Snippet

Sponsor: Saol Therapeutics Inc | Conditions: Spasticity | Phase 2 | Status: UNKNOWN